• By ICR Secretariat
  • Posted Monday, July 29, 2019

As new prime minister takes the helm, U.K.-based GSK still balks at 'no deal'


It wasn’t the best timing for GlaxoSmithKline’s second-quarter financial call: While CEO Emma Walmsley went through the numbers, Britain’s Prime Minister Theresa May was giving her last speech as prime minister in Parliament.